Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-19-057596

Director sold 7,500 shares at $62.00 ($465,000)

  • Director acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CAGNONI PABLO J Director 2019-11-19 Option exercise +7,500 $5.59 $41,925 7,500 D
CAGNONI PABLO J Director 2019-11-19 Sale −7,500 $62.00 $465,000 0 D
Derivatives
CAGNONI PABLO J Director 2019-11-19 Option exercise · Stock Option (Right to Buy) −7,500 63,833 D
Open-market sales · 7,500 sh · avg $62.00 · $465,000
Loading xslF345X03/doc4.xml…